Brandon J. Baartman, M.D.

EDUCATION

B.A., Gustavus Adolphus College , St. Peter, Minnesota. 2005-2009.

M.D., Wake Forest School of Medicine, Winston-Salem, North Carolina. 2009-2013.

Transitional Year Internship, Gundersen Lutheran Medical Foundation , La Crosse , Wisconsin. 2013-2014

Residency , Ophthalmology , Cole Eye Institute, Cleveland Clinic, Cleveland , Ohio. 2014-2017

HONORS AND AWARDS

  • Chief Resident in Ophthalmology , Cole Eye Institute , Cleveland Clinic, 2016-2017
  • Excellence in Teaching Award, Cleveland Clinic Educational Foundation , 2016
  • Alpha Omega Alpha Medical Honor Society, 2013
  • David Bryan Sloan III, MD Award for Excellence in Ophthalmolog y. Wake Forest School of Medicine, 2013
  • Pennell Pro Humanitate Vitae Award for International Health Studies. Wake Forest School of Medicine , 2012
  • Pennell Pro Humanitate Vitae Award for International Health Studies. Wake Fore st School of Medicine , 2010
  • Jacobson Award for International Pre-Medical Studies. Gustavus Adolphus College , 2008

CLINICAL TRIALS

  • A Controlled, Cohort, Open-Label, Randomized Study to Evaluate the Application of Negative Pressure Applieto the Periocular Microen vironment Anterior to the Orbital Rim to Alter Visual Evoked Potential (YEP) and Pattern Electroretinography (ERG) Readings by way of Modulating Intraocular Pressure (IOP)
    • Sponsor: Equinox, LLC
    • My Role: Sub-Investigator
  • A Prospective, Randomized , Controlled, Open-Label Study to Evaluate the Safety and Proof of Concept of Negative Pressure Applied to the Periocular Microenvironment Anterior to the Orbital Rim to Alter Spontaneous Venous Pulsations (SVP) by way of Modulating Intraocular Pressure (IOP)
    • Sponsor: Equinox, LLC
    • My Role: Principal Investigator
  • A Prospective, Randomized, Controlled, Multi-Center Clinical Study of the ACRYSOF IQ Extended Depth of Focus IOL
    • Sponsor: Alcon
    • My Role: Sub-Investigator
  • Clinical Investigation of ACRYSOF IQ PanOptix IOL Model TFNT00
    • Sponsor: Alcon
    • My Role: Sub-Investigator
  • Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
    • Sponsor: Bausch & Lomb Incorporated
    • My Role: Sub-Investigator

Website

vancetompsonvision.com

PUBLICATIONS

  • Baartman BJ, Sudhagoni R, Swan R, Greenwood M, Berdahl J. Re: Linden et al.: Normal-tension glaucoma has normal intracranial pressure: a prospective study of intracranial pressure and intraocular pressure in different body positions. Ophthalmology. 2018; 125:361 e368
  • Baartman BJ, Berdahl JP. Recent Advances in the Understanding and Treatment of Glaucoma. US Ophthalmic Review, 2017; 10(2):89-90 .
  • Baartman BJ, Gans R, Goshe J. Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema . Can J Ophthalmol. 2017. Manuscript Accepted 14 Aug 2017.
  • Baartman BJ, Nguyen L, Wiest P, Steinemann TL. Ocular Loiasis in Ohio: a case report. Int Ophthalmol. 2017. doi: 10.1007/s10792-0l 7-0663-7
  • Baartman BJ, Adamopoulou C. Isolated abducens palsy heralding occult HIV-related lymphoma. Neuro-Ophthalmology. Published Online 08 Jun 2017
  • Carrera W, Baartman BJ, Kosmorsky G. A case report of drug-induced myopathy involving extraocular muscles after combination therapy with tremelimumab and durvalumab for non-small cell lung cancer. Neuro-Ophthalmology. 2017;Mar 15;41(3):140-143
  • Kump SK, McClintic JI, Allen JC, Baartman BJ, Altaweel MM, Garg SJ, Quiroz-Mercado H. Viscoelasti cassisted drainage of suprachoroidal hemorrhage associated with seton device in glaucoma filtering surgery. Retina. 2017;37(2):396-399
  • Baartman BJ, Ahmad B, Srivastava S, Jones S, Singh AD. Melanocytoma or Juxtapap illary Melanoma? Retina Cases and Brief Rep. 2017. doi: 10.1097/ICB.0000000000000520